Design of transdermal matrix patch containing ondansetron
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, J.-R. | - |
dc.contributor.author | Van Duong, A. | - |
dc.contributor.author | Nguyen, L.T.T. | - |
dc.contributor.author | Chi, S.-C. | - |
dc.date.available | 2020-02-28T03:44:38Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2093-5552 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8878 | - |
dc.description.abstract | Ondansetron was formulated into a transdermal matrix patch to reduce side effects and improve patient compliance. The effects of adhesive (polyisobutylene rubber, acrylic, and styrene butadiene rubber), crosslinker content (aluminum), vehicle (lactic acid), and drug amount on ondansetron skin permeation rate were investigated using excised hairless mouse skin with a flow-through diffusion cell system. Acrylic adhesive resulted in a higher ondansetron permeation rate than that of other adhesives. The ondansetron matrix patch prepared with acrylic adhesive without the crosslinker showed the highest permeation rate of 0.92 µg/cm2/h. Adding the crosslinker to the matrix patch reduced ondansetron skin permeation rate. The molecular weight and functional group of adhesive did not affect skin permeation of ondansetron from the matrix patch. As the amount of ondansetron in the matrix patch was increased (2.0–6.5 %), skin permeation rate increased up to 5 % of the drug, which was unchanged beyond this concentration. Based on these results, the optimum formulation for an ondansetron matrix patch consisted of 5 % ondansetron, 5 % lactic acid, 19.9 % N-methyl-2-pyrrolidone, 5 % ethyl oleate, 2 % glycerol monooleate, and 63.1 % acrylic adhesive (SK 1570-50F). This optimized matrix patch resulted in a skin permeation rate of 1.01 ± 0.21 µg/cm2/h through excised hairless mouse skin. © 2016, The Korean Society of Pharmaceutical Sciences and Technology. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Springer Netherlands | - |
dc.relation.isPartOf | Journal of Pharmaceutical Investigation | - |
dc.subject | 1 methyl 2 pyrrolidinone | - |
dc.subject | acrylic cement | - |
dc.subject | functional group | - |
dc.subject | glycerol oleate | - |
dc.subject | lactic acid | - |
dc.subject | oleic acid ethyl ester | - |
dc.subject | ondansetron | - |
dc.subject | animal tissue | - |
dc.subject | Article | - |
dc.subject | controlled study | - |
dc.subject | cross linking | - |
dc.subject | drug formulation | - |
dc.subject | female | - |
dc.subject | high performance liquid chromatography | - |
dc.subject | membrane transport | - |
dc.subject | molecular weight | - |
dc.subject | mouse | - |
dc.subject | nonhuman | - |
dc.subject | priority journal | - |
dc.subject | transdermal patch | - |
dc.title | Design of transdermal matrix patch containing ondansetron | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.1007/s40005-016-0273-9 | - |
dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.46, no.7, pp.677 - 684 | - |
dc.identifier.kciid | ART002173281 | - |
dc.identifier.scopusid | 2-s2.0-85007609820 | - |
dc.citation.endPage | 684 | - |
dc.citation.startPage | 677 | - |
dc.citation.title | Journal of Pharmaceutical Investigation | - |
dc.citation.volume | 46 | - |
dc.citation.number | 7 | - |
dc.contributor.affiliatedAuthor | Van Duong, A. | - |
dc.contributor.affiliatedAuthor | Nguyen, L.T.T. | - |
dc.contributor.affiliatedAuthor | Chi, S.-C. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Adhesive | - |
dc.subject.keywordAuthor | Ondansetron | - |
dc.subject.keywordAuthor | Patch | - |
dc.subject.keywordAuthor | Transdermal | - |
dc.subject.keywordPlus | 1 methyl 2 pyrrolidinone | - |
dc.subject.keywordPlus | acrylic cement | - |
dc.subject.keywordPlus | functional group | - |
dc.subject.keywordPlus | glycerol oleate | - |
dc.subject.keywordPlus | lactic acid | - |
dc.subject.keywordPlus | oleic acid ethyl ester | - |
dc.subject.keywordPlus | ondansetron | - |
dc.subject.keywordPlus | animal tissue | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | cross linking | - |
dc.subject.keywordPlus | drug formulation | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | high performance liquid chromatography | - |
dc.subject.keywordPlus | membrane transport | - |
dc.subject.keywordPlus | molecular weight | - |
dc.subject.keywordPlus | mouse | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | transdermal patch | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.